SEC Filings

Filing date	Form	Description	View
01/05/24	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-001556.pdf 0001104659-24-001556.rtf 0001104659-24-001556.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
12/28/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-129824.pdf 0001104659-23-129824.rtf 0001104659-23-129824.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
12/26/23	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-23-016940.pdf 0001415889-23-016940.rtf 0001415889-23-016940.xls
12/26/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-016943.pdf 0001415889-23-016943.rtf 0001415889-23-016943.xls
12/21/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-128299.pdf 0001104659-23-128299.rtf 0001104659-23-128299.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
12/21/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-128307.pdf 0001104659-23-128307.rtf
11/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-015446.pdf 0001415889-23-015446.rtf 0001415889-23-015446.xls
11/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-015450.pdf 0001415889-23-015450.rtf 0001415889-23-015450.xls
11/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-015448.pdf 0001415889-23-015448.rtf 0001415889-23-015448.xls
11/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-015452.pdf 0001415889-23-015452.rtf 0001415889-23-015452.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.